Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Rosetta Genomics Ltd (NASDAQ:ROSG)

0.83
Delayed Data
As of Sep 30
 +0.0006 / +0.07%
Today’s Change
0.71
Today|||52-Week Range
2.68
-32.52%
Year-to-Date
Institutional investors purchased a net $34.1 thousand shares of ROSG during the quarter ended March 2016 and now own 6.72% of the total shares outstanding. This is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Other institutional6.48%
Mutual fund holders0.24%
Individual stakeholders--

Largest Quarterly Institutional
Transactions

Chart unavailable

Latest Institutional Activity

Top 10 Owners of Rosetta Genomics Ltd

StockholderStakeShares
owned
Total value ($)Shares
bought / sold
Total
change
Highlander Capital Management LLC2.48%517,545502,019-6,100-1.16%
Empery Asset Management LP1.85%386,136374,552-645,114-62.56%
Morgan Stanley & Co. LLC1.41%293,100284,307+52,763+21.95%
The California Public Employees R...0.24%50,60949,09100.00%
Philadelphia Investment Partners ...0.24%50,00048,500+4,500+9.89%
UBS Securities LLC0.20%42,48841,213+41,916+7,327.97%
KCG Americas LLC0.12%25,00524,255-35,118-58.41%
G1 Execution Services LLC0.10%21,39020,748+6,835+46.96%
Investors Capital Corp.0.05%11,00010,670-800-6.78%
Wells Fargo Advisors Financial Ne...0.01%2,0001,940+1,000+100.00%

Top 10 Mutual Funds Holding Rosetta Genomics Ltd

Mutual fundStakeShares
owned
Total value ($)Shares
bought / sold
Total
change
Philadelphia Investment Partners ...0.24%50,00048,500+4,500+9.89%